Literature DB >> 17082261

Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.

Jens Mittag1, Elke Winterhager, Karl Bauer, Ruth Grümmer.   

Abstract

Absence of the Pax8 gene results in congenital hypothyroidism in mice, and mutations of the Pax8 gene have been associated with thyroid hypoplasia in humans. As in humans, treatment of congenital hypothyroid Pax8 null mice with thyroxine normalizes the known deficits. However, we report here that thyroxine-substituted female Pax8(-/-) mice are infertile because they lack a functional uterus revealing only remnants of myometrial tissue. In addition, the vaginal opening is absent. Interestingly, oviduct, cervix, and upper parts of the vagina are not affected, although Pax8 expression has been described in the entire Müllerian duct before. Because the natural outflow of the oviduct is impaired, a hydrosalpinx develops frequently. Folliculogenesis, ovarian hormone production, and transcription of pituitary hormones are in a normal range. Thus, infertility in Pax8(-/-) mice seems to be due to a defect in development of the Müllerian duct rather than to hormonal imbalance, pointing to a direct morphogenic role for Pax8 in uterine development. Because we demonstrated Pax8 expression not only in the uterine epithelium of mice but also in the human endometrium, it remains to be elucidated whether adequate development of the uterus may also be affected in congenital hypothyroid female patients with mutations in the Pax8 gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082261     DOI: 10.1210/en.2006-1054

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  43 in total

1.  The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.

Authors:  Gaëlle Gendronneau; Olivier Boucherat; Josée Aubin; Margot Lemieux; Lucie Jeannotte
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

2.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Authors:  Ruth Perets; Gregory A Wyant; Katherine W Muto; Jonathan G Bijron; Barish B Poole; Kenneth T Chin; Jin Yun H Chen; Anders W Ohman; Corey D Stepule; Soongu Kwak; Alison M Karst; Michelle S Hirsch; Sunita R Setlur; Christopher P Crum; Daniela M Dinulescu; Ronny Drapkin
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

3.  Uterine Paramesonephric Cysts in Sprague-Dawley Rats from National Toxicology Program Studies.

Authors:  Daven N Jackson-Humbles; John Curtis Seely; Ronald A Herbert; David E Malarkey; Barry S McIntyre; Paul M Foster; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2018-04-29       Impact factor: 1.902

4.  Perturbations of genes essential for Müllerian duct and Wölffian duct development in Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Na Chen; Sen Zhao; Angad Jolly; Lianlei Wang; Hongxin Pan; Jian Yuan; Shaoke Chen; André Koch; Congcong Ma; Weijie Tian; Ziqi Jia; Jia Kang; Lina Zhao; Chenglu Qin; Xin Fan; Katharina Rall; Zeynep Coban-Akdemir; Zefu Chen; Shalini Jhangiani; Ze Liang; Yuchen Niu; Xiaoxin Li; Zihui Yan; Yong Wu; Shuangshuang Dong; Chengcheng Song; Guixing Qiu; Shuyang Zhang; Pengfei Liu; Jennifer E Posey; Feng Zhang; Guangnan Luo; Zhihong Wu; Jianzhong Su; Jianguo Zhang; Eugenia Y Chen; Konstantinos Rouskas; Stavros Glentis; Flora Bacopoulou; Efthymios Deligeoroglou; George Chrousos; Stanislas Lyonnet; Michel Polak; Carla Rosenberg; Irene Dingeldein; Ximena Bonilla; Christelle Borel; Richard A Gibbs; Jennifer E Dietrich; Antigone S Dimas; Stylianos E Antonarakis; Sara Y Brucker; James R Lupski; Nan Wu; Lan Zhu
Journal:  Am J Hum Genet       Date:  2021-02-04       Impact factor: 11.025

5.  Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Damanzoopinder Samrao; Heidi Godoy; Faith Ough; Song Liu; Tanja Pejovic; Shashikant Lele
Journal:  Gynecol Oncol       Date:  2012-06-15       Impact factor: 5.482

6.  Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.

Authors:  Hiu Wing Cheung; Glenn S Cowley; Barbara A Weir; Jesse S Boehm; Scott Rusin; Justine A Scott; Alexandra East; Levi D Ali; Patrick H Lizotte; Terence C Wong; Guozhi Jiang; Jessica Hsiao; Craig H Mermel; Gad Getz; Jordi Barretina; Shuba Gopal; Pablo Tamayo; Joshua Gould; Aviad Tsherniak; Nicolas Stransky; Biao Luo; Yin Ren; Ronny Drapkin; Sangeeta N Bhatia; Jill P Mesirov; Levi A Garraway; Matthew Meyerson; Eric S Lander; David E Root; William C Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

7.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

8.  PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.

Authors:  Dima Ghannam-Shahbari; Eyal Jacob; Reli Rachel Kakun; Tanya Wasserman; Lina Korsensky; Ofir Sternfeld; Juliana Kagan; Debora Rosa Bublik; Sarit Aviel-Ronen; Keren Levanon; Edmond Sabo; Sarit Larisch; Moshe Oren; Dov Hershkovitz; Ruth Perets
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

9.  Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.

Authors:  Yiying Wang; Li Li; Yue Wang; Sarah Ngocvi Tang; Wenxin Zheng
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

10.  Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.

Authors:  Kevin M Elias; Megan M Emori; Thomas Westerling; Henry Long; Anna Budina-Kolomets; Fugen Li; Emily MacDuffie; Michelle R Davis; Alexander Holman; Brian Lawney; Matthew L Freedman; John Quackenbush; Myles Brown; Ronny Drapkin
Journal:  JCI Insight       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.